Navigation Links
aRNA Synthesis and Labeling for Array Analysis

Amino Allyl MessageAmp II aRNA Amplification Kits-- Now Available with Cy Dyes
Extremely sensitive
ArrayScript Reverse Transcriptase--high yields of full-length cDNA increases aRNA yields

MEGAscript transcription technology-- up to 4000-fold amplification of mRNA

Optimized buffers--high dye coupling efficiency

Maximum flexibility

Configured for 20 single round amplifications or 10 two round amplifications

Available with Cy3, Cy5, both Cy3 & Cy5, or without dyes

Sufficient aRNA for most microarray analyses from a four hour in vitro transcription reaction (>500 ng input RNA)

Labeling aRNA

Several different methods can be used to label amplified antisense RNA (aRNA) for array analysis. Cy dyes, other fluorophores, or biotin can be incorporated: 1) during the in vitro transcription (IVT) step of aRNA synthesis via modified-rNTP incorporation (direct labeling), 2) during a subsequent reverse transcription reaction via modified-dNTP incorporation (direct labeling), or 3) in a coupling reaction after aRNA synthesis where the label is added to an amino allyl-modified rNTP incorporated during IVT or reverse transcription (indirect labeling). Increasingly, amino allyl incorporation combined with a secondary dye coupling reaction is being used for the generation of samples for array analysis.

Advantages of Indirect Labeling

Direct incorporation of labeled NTPs is inefficient and results in low yields and low specific activity aRNA. This can make the cost of producing aRNA by direct incorporation very high. In addition, incorporation efficiency varies for different labels (e.g. Cy3 NTP vs. Cy5 NTP). These problems can be avoided by indirect labeling, whereby an amino allyl NTP is incorporated into the aRNA, and the reactive amino group is subsequently coupled with an NHS ester label (e.g. biotin, Cy dye). Compared to dye-coupled NTPs, amino allyl modified NTPs are incorporated almost as efficiently as unmodified NTPs by ArrayScript Reverse Transcriptase (Cat# 2048) and are much less expensive. Figures 1 and 2 demonstrate equivalent labeling with Cy3 and Cy5 dyes using the Amino Allyl MessageAmp II aRNA Amplification Kit.

Figure 1. aRNA Yields From Amino Allyl MessageAmp II aRNA Amplification Kit. The indicated amounts of Control RNA (HeLa cell total RNA) were amplified for the in vitro transcription (IVT) incubation times indicated. While longer IVT incubation times produced more aRNA, the amount of aRNA required for most microarrays was obtained with a four hour incubation with >500 ng of input RNA. This data was obtained using the Control RNA provided with the Amino Allyl MessageAmp II aRNA Amplification Kit. Note that aRNA yields can vary considerably with sample quality.

Figure 2. Scatter Plot Demonstrating Equivalent Labeling. Scatter plot showing signal intensities of Cy3 vs. Cy5 labeled aRNA synthesized with the Amino Allyl MessageAmp II aRNA Kit.

Now Available with Cy dyes

For versatility and convenience, the new Amino Allyl MessageAmp II aRNA Kit can be ordered with Cy3, Cy5, Cy3 and Cy5, or without label. Other nonisotopic labels, available from Amersham Biosciences, Molecular Probes, and Pierce, can also be coupled to the amino allyl moiety.

Improved Kit for High Yield and High Reproducibility

The Amino Allyl MessageAmp aRNA Amplification Kit was the first kit that integrated amino allyl incorporation with RNA amplification. The new Amino Allyl MessageAmp II aRNA Kit includes extensive improvements to the original kit. Both kits contain all the components needed to perform RNA amplification, including reagents for first- and second-strand cDNA synthesis, cDNA purification, large scale in vitro transcription, and aRNA purification. Additionally, both kits include Ambion's highly purified amino allyl UTP, and reagents for Cy dye coupling and clean-up. The final purification step has been optimized for thorough removal of excess dye to ensure very low background signal on arrays.

The Amino Allyl MessageAmp II aRNA Amplification Kit uses ArrayScript to maximize conversion of first-strand cDNA into full-length double-stranded cDNA templates [1]. Buffers have been modified to increase labeling efficiency, and each step of the protocol has been optimized for high yields and reproducibility. Starting with 2 g of total RNA (~60 ng mRNA), a single round of amplification using the Amino Allyl MessageAmp Kit will yield up to 150 g aRNA. This represents a 2500-fold amplification of mRNA. In addition, as little as 10 ng total RNA (300 pg mRNA) can be amplified in a single round to produce more than 1 g aRNA.

Amino Allyl MessageAmp is covered by patents exclusively licensed to Incyte Genomics

Scientific Contributors
Sharmili Moturi, Joe Ehardt Ambion, Inc.

back to top

Ordering Information Cat# Product Name Size 1752 Amino Allyl MessageAmp aRNA Kit 20 rxns 1753 Amino Allyl MessageAmp II aRNA Amplification Kit 20 rxns 1795 Amino Allyl MessageAmp II with Cy3 20 rxns 1796 Amino Allyl MessageAmp II with Cy5 20 rxns 1797 Amino Allyl MessageAmp II with Cy3/Cy5 (1:3) 20 rxns 1821 Amino Allyl MessageAmp II-96 aRNA Amplification Kit 100 rxns


Page: All 1 2 3 4 5

Related biology technology :

1. Custom siRNA Oligo Synthesis Service
2. Increase the Power and Sensitivity for Your cDNA Synthesis with the New Transcriptor Reverse Transcriptase
3. Microarray Target Purification Kit and the Microarray Target Synthesis Kit (T7)
4. Direct Monitoring of Solid-Phase Peptide Synthesis by MALDI-TOF MS
5. New Microarray Labeling Kit for Preparing cDNA Probes
6. Amino Allyl Labeling for Array Analysis
7. Fluorescently Labeling Long dsRNA with the Silencer siRNA Labeling Kit
8. Efficient Europium Labeling of Lymphokine-Activated Killer Cells Using the Gene Pulser II with RF Module, Rev C
9. USB OptiKinase Eliminates Base Bias in Labeling of Oligonucleotide 5-Ends
10. Innovative Tissue Array Technology for High-Throughput Screening of Gene Expression
11. Human Universal cDNA Library Array I
Post Your Comments:

(Date:10/13/2015)... ... October 13, 2015 , ... SonaCare Medical, LLC, ... that it received de novo clearance from the U.S. Food and Drug Administration ... of prostate tissue. Sonablate® is the first High Intensity Therapeutic Ultrasound (HITU) device ...
(Date:10/12/2015)... and BRUSSELS , Oct. 12, 2015 /PRNewswire/ ... today presented additional findings from an exploratory sub-study of the ... were presented today in an oral plenary session at the ... Meeting in Seattle . 2 ... The small exploratory sub-study data showed that, at month ...
(Date:10/12/2015)... Oct. 12, 2015  Rebiotix Inc. today announced ... designated its lead Microbiota Restoration Therapy (MRT) RBX2660 ... recurrent Clostridium difficile (C diff) infection, ... causes 29,000 deaths in the U.S. annually. 1 ... that was founded to revolutionize the treatment of ...
(Date:10/12/2015)...  Patara Pharma, a clinical-stage biotechnology company developing ... conditions, today announced the closing of a $26 ... the close of its sale of preferred stock, ... Agreement with Silicon Valley Bank whereby the Company ... use the funds from the financing to evaluate ...
Breaking Biology Technology:
(Date:10/8/2015)... NXT-ID, Inc. (NASDAQ: ... authentication company focused on the growing mobile commerce ... announces that revenues for the three months ended ... $113,00 for the three months ended June 30, ... 30, 2015 were approximately $520,000.      ...
(Date:10/5/2015)... ) releases the following ... NXTD ), a biometric authentication company focused on the ... ) releases the following market and company update ... authentication company focused on the growing mobile commerce market. ... ) releases the following market and company update ...
(Date:9/30/2015)... global glucose monitoring device and diabetes management market is valued ... on the industry from Kalorama Information. Sales in the traditional glucose ... continuous glucose monitoring and sensor segment, according to the healthcare ... in its latest report, The Global Glucose Monitoring Market ... , ...
Breaking Biology News(10 mins):